Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gary S. Jacob currently holds 112,420 shares of Hepion Pharmaceuticals, Inc. (HEPA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gary S. Jacob has been a net buyer of HEPA stock. They have purchased $184.3K and sold $0 worth of shares.
Gary S. Jacob's most recent insider trade was on Jul 21, 2026, when they sold 3,500 shares at $1.40 per share.
Gary S. Jacob serves as Executive at Hepion Pharmaceuticals, Inc. (HEPA). They have executed 22 insider transactions totaling $184.3K over their tenure at the company.
Gary S. Jacob holds the position of Executive at Hepion Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Gary S. Jacob has shown a buying trading pattern, with $184.3K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Gary S. Jacob was on Jul 1, 2015, when they sold $353.2K worth of SGYP shares. This transaction involved 62,965 shares at $5.61 per share.
Gary S. Jacob currently owns 112,420 shares of Hepion Pharmaceuticals, Inc. (HEPA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gary S. Jacob's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gary S. Jacob has 22 Form 4 filings on record as an insider at Hepion Pharmaceuticals, Inc..
Set alerts for Gary S. Jacob and 40,000+ other insiders.